부산대학교 도서관

Duong BQ; Arwood MJ; Hicks JK; Beitelshees AL; Franchi F; Houder JT; Limdi NA; Cook KJ; Owusu Obeng A; Petry N; Tuteja S; Elsey AR; Cavallari LH; Wiisanen K

Pharmacogenomics and Personalized Medicine, Vol Volume 13, Pp 217-226 (2020)

Alontaga AY; Department of Thoracic Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida.; Cano P; Department of Pathology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida.; Ozakinci H; Department of Thoracic Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida.; Puskas JA; Department of Pathology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida.; Stewart PA; Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida.; Welsh EA; Biostatistics and Bioinformatics Shared Resource, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida.; Yoder SJ; Molecular Genomics Core Facility, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida.; Hicks JK; Department of Pathology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida.; Saltos AN; Department of Thoracic Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida.; Bossler AD; Department of Pathology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida.; Haura EB; Department of Thoracic Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida.; Koomen JM; Department of Pathology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida; Department of Molecular Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida.; Boyle TA; Department of Thoracic Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida; Department of Pathology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida. Electronic address: theresa.boyle@moffitt.org.

Publisher: Elsevier Country of Publication: United States NLM ID: 100893612 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1943-7811 (Electronic) Linking ISSN: 15251578 NLM ISO Abbreviation: J Mol Diagn Subsets: MEDLINE

Tracksdorf T; Deparment of Clinical Pharmacy, University of Michigan College of Pharmacy, 428 Church St, Room 2560C, Ann Arbor, MI, 48109-1065, USA.; Smith DM; Department of Oncology, Georgetown University Medical Center, Washington, DC, USA.; MedStar Health, Columbia, MD, USA.; Pearse S; Health Behavior and Health Education, School of Public Health, University of Michigan, Ann Arbor, MI, USA.; Cicali EJ; Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, FL, USA.; Center for Pharmacogenomics and Precision Medicine, University of Florida, Gainesville, FL, USA.; Aquilante CL; Department of Pharmaceutical Sciences, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO, USA.; Colorado Center for Personalized Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.; Scott SA; Department of Pathology, Stanford University, Stanford, CA, USA.; Clinical Genomics Laboratory, Stanford Medicine, Palo Alto, CA, USA.; Ho TT; Department of Pathology, Moffitt Cancer Center, Tampa, FL, USA.; Patel JN; Department of Cancer Pharmacology and Pharmacogenomics, Atrium Health Levine Cancer Institute, Charlotte, NC, USA.; Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC, USA.; Hicks JK; Department of Pathology, Moffitt Cancer Center, Tampa, FL, USA.; Hertz DL; Deparment of Clinical Pharmacy, University of Michigan College of Pharmacy, 428 Church St, Room 2560C, Ann Arbor, MI, 48109-1065, USA. DLHertz@med.umich.edu.

Publisher: Springer International Country of Publication: Germany NLM ID: 9302957 Publication Model: Electronic Cited Medium: Internet ISSN: 1433-7339 (Electronic) Linking ISSN: 09414355 NLM ISO Abbreviation: Support Care Cancer Subsets: MEDLINE

Hayes TK; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA.; Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA, USA.; Aquilanti E; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA.; Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Persky NS; Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Genetic Perturbation Platform, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Aera Therapeutics, Cambridge, MA, USA.; Yang X; Genetic Perturbation Platform, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Kim EE; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA.; Brenan L; Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Goodale AB; Genetic Perturbation Platform, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Alan D; Genetic Perturbation Platform, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Sharpe T; Data Science Platform, The Broad Institute of M.I.T. and Harvard Cambridge, Cambridge, MA, USA.; Shue RE; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA.; Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Westlake L; Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Golomb L; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA.; Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Silverman BR; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA.; Morris MD; Summer Honors Undergraduate Research Program, Harvard Medical School, Boston, MA, USA.; Fisher TR; Summer Honors Undergraduate Research Program, Harvard Medical School, Boston, MA, USA.; Beyene E; Summer Honors Undergraduate Research Program, Harvard Medical School, Boston, MA, USA.; Li YY; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA.; Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Cherniack AD; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA.; Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Piccioni F; Genetic Perturbation Platform, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Merck Research Laboratories, Cambridge, MA, USA.; Hicks JK; Department of Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Chi AS; Center for Neuro-Oncology, Division of Neuro-Oncology, Massachusetts General Hospital, Boston, MA, USA.; Cahill DP; Center for Neuro-Oncology, Division of Neuro-Oncology, Massachusetts General Hospital, Boston, MA, USA.; Dietrich J; Department of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital, Boston, MA, USA.; Batchelor TT; Department of Neurology, Brigham and Women's Hospital & Harvard Medical School, Boston, MA, USA.; Root DE; Genetic Perturbation Platform, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Johannessen CM; Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Department of Oncology, Novartis Institutes for Biomedical Research, Cambridge, MA, USA.; Meyerson M; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA. matthew_meyerson@dfci.harvard.edu.; Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA. matthew_meyerson@dfci.harvard.edu.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: PubMed not MEDLINE; MEDLINE

Brock P; Division of Human Genetics, The Ohio State University College of Medicine, Comprehensive Cancer Center, Columbus, Ohio, USA.; Liynarachchi S; Department of Molecular Medicine and Therapeutics, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.; Nieminen TT; Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland.; Chan C; Holden Comprehensive Cancer Center, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA.; Kohlmann W; University of Utah, Huntsman Cancer Institute, Salt Lake City, Utah, USA.; Stout LA; Indiana University School of Medicine, Indianapolis, Indiana, USA.; Yao S; Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.; La Greca A; Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado, Aurora, Colorado, USA.; Jensen KE; Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.; Kolesar JM; College of Pharmacy, University of Kentucky, Lexington, Kentucky, USA.; Salhia B; Department of Translational Genomics, Norris Comprehensive Cancer Center, Keck School of Medicine of University of Southern California, Los Angeles, California, USA.; Gulhati P; Department of Medical Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.; Hicks JK; Department of Pathology, Moffitt Cancer Center, Tampa, Florida, USA.; Ringel MD; Department of Molecular Medicine and Therapeutics, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.

Publisher: Mary Ann Liebert Publishers Country of Publication: United States NLM ID: 9104317 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-9077 (Electronic) Linking ISSN: 10507256 NLM ISO Abbreviation: Thyroid Subsets: MEDLINE

Hayes TK; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA.; Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA, USA.; Aquilanti E; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA.; Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Persky NS; Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Genetic Perturbation Platform, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Aera Therapeutics, Cambridge, MA, USA.; Yang X; Genetic Perturbation Platform, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Kim EE; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA.; Brenan L; Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Goodale AB; Genetic Perturbation Platform, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Alan D; Genetic Perturbation Platform, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Sharpe T; Data Science Platform, The Broad Institute of M.I.T. and Harvard Cambridge, Cambridge, MA, USA.; Shue RE; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA.; Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Westlake L; Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Golomb L; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA.; Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Silverman BR; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA.; Morris MD; Summer Honors Undergraduate Research Program, Harvard Medical School, Boston, MA, USA.; Fisher TR; Summer Honors Undergraduate Research Program, Harvard Medical School, Boston, MA, USA.; Beyene E; Summer Honors Undergraduate Research Program, Harvard Medical School, Boston, MA, USA.; Li YY; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA.; Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Cherniack AD; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA.; Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Piccioni F; Genetic Perturbation Platform, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Merck Research Laboratories, Cambridge, MA, USA.; Hicks JK; Department of Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Chi AS; Center for Neuro-Oncology, Division of Neuro-Oncology, Massachusetts General Hospital, Boston, MA, USA.; Cahill DP; Center for Neuro-Oncology, Division of Neuro-Oncology, Massachusetts General Hospital, Boston, MA, USA.; Dietrich J; Department of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital, Boston, MA, USA.; Batchelor TT; Department of Neurology, Brigham and Women's Hospital & Harvard Medical School, Boston, MA, USA.; Root DE; Genetic Perturbation Platform, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Johannessen CM; Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA.; Department of Oncology, Novartis Institutes for Biomedical Research, Cambridge, MA, USA.; Meyerson M; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA. matthew_meyerson@dfci.harvard.edu.; Cancer Program, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, USA. matthew_meyerson@dfci.harvard.edu.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Ho TT; Department of Pharmacotherapeutics & Clinical Research, University of South Florida Taneja College of Pharmacy, Tampa, FL 33612, USA.; Department of Pathology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.; Perkins JB; Department of Pharmacotherapeutics & Clinical Research, University of South Florida Taneja College of Pharmacy, Tampa, FL 33612, USA.; Gonzalez R; Department of Blood & Marrow Transplant & Cellular Immunotherapy (BMT CI), H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.; Department of Pharmacy, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.; Hicks JK; Department of Pathology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.; Martinez RA; Department of Pharmacotherapeutics & Clinical Research, University of South Florida Taneja College of Pharmacy, Tampa, FL 33612, USA.; Duranceau K; Department of Pharmacotherapeutics & Clinical Research, University of South Florida Taneja College of Pharmacy, Tampa, FL 33612, USA.; North B; Department of Pharmacotherapeutics & Clinical Research, University of South Florida Taneja College of Pharmacy, Tampa, FL 33612, USA.; Kim J; Department of Biostatistics & Bioinformatics, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.; Teer JK; Department of Biostatistics & Bioinformatics, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.; Yao J; Department of Biostatistics & Bioinformatics, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.; Yoder SJ; Molecular Genomics Core, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.; Nishihori T; Department of Blood & Marrow Transplant & Cellular Immunotherapy (BMT CI), H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.; Bejanyan N; Department of Blood & Marrow Transplant & Cellular Immunotherapy (BMT CI), H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.; Pidala J; Department of Blood & Marrow Transplant & Cellular Immunotherapy (BMT CI), H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.; Elmariah H; Department of Blood & Marrow Transplant & Cellular Immunotherapy (BMT CI), H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.

Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 100897350 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8042 (Electronic) Linking ISSN: 14622416 NLM ISO Abbreviation: Pharmacogenomics Subsets: MEDLINE

Mosley SA; Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision Medicine, University of Florida, Gainesville, Florida, USA.; Department of Clinical Pharmacy, University of Southern California, Los Angeles, California, USA.; Cicali E; Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision Medicine, University of Florida, Gainesville, Florida, USA.; Del Cueto A; Department of Individualized Cancer Management, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.; Portman DG; Department of Supportive Care Medicine, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.; Donovan KA; Department of Supportive Care Medicine, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.; Gong Y; Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision Medicine, University of Florida, Gainesville, Florida, USA.; Langaee T; Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision Medicine, University of Florida, Gainesville, Florida, USA.; Gopalan P; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, Florida, USA.; Schmit J; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, Florida, USA.; Starr JS; Division of Hematology/Oncology, Mayo Clinic, Jacksonville, Florida, USA.; Silver N; Department of Otolaryngology, College of Medicine, University of Florida, Gainesville, Florida, USA.; Chang YD; Department of Supportive Care Medicine, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.; Rajasekhara S; Department of Supportive Care Medicine, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.; Smith JE; Department of Supportive Care Medicine, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.; Soares HP; Department of Gastrointestinal Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.; Clare-Salzler M; Department of Pathology, Immunology & Laboratory Medicine, College of Medicine, University of Florida, Gainesville, Florida, USA.; Starostik P; Department of Pathology, Immunology & Laboratory Medicine, College of Medicine, University of Florida, Gainesville, Florida, USA.; George TJ; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, Florida, USA.; McLeod HL; Intermountain Health, St George, Utah, USA.; Fillingim RB; Department of Community Dentistry and Behavioral Science, College of Dentistry, Gainesville, Florida, USA.; Clinical and Translational Science Institute, University of Florida, Gainesville, Florida, USA.; Hicks JK; Department of Individualized Cancer Management, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.; Cavallari LH; Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision Medicine, University of Florida, Gainesville, Florida, USA.

Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 8111305 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1875-9114 (Electronic) Linking ISSN: 02770008 NLM ISO Abbreviation: Pharmacotherapy Subsets: MEDLINE

Hertz DL; Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, Michigan, USA.; Smith DM; Department of Oncology, Georgetown University Medical Center, Washington, DC, USA.; MedStar Health, Columbia, Maryland, USA.; Scott SA; Department of Pathology, Stanford University, Stanford, California, USA.; Clinical Genomics Laboratory, Stanford Medicine, Palo Alto, California, USA.; Patel JN; Department of Cancer Pharmacology and Pharmacogenomics, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina, USA.; Hicks JK; Department of Individualized Cancer Management, Moffitt Cancer Center, Tampa, Florida, USA.

Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE

Hicks JK; Department of Individualized Cancer Management, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA. James.hicks@moffitt.org.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9302235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5438 (Electronic) Linking ISSN: 10184813 NLM ISO Abbreviation: Eur J Hum Genet Subsets: MEDLINE